| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/1998 | EP0850237A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| 07/01/1998 | EP0850236A1 Piperazino derivatives as neurokinin antagonists |
| 07/01/1998 | EP0850235A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 07/01/1998 | EP0850234A1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 07/01/1998 | EP0850233A1 Retinoids and methods of use of same |
| 07/01/1998 | EP0850232A1 Benzothiazolone derivatives |
| 07/01/1998 | EP0850230A1 Pyrrolidine and thiazole derivatives with antibacterial and metallo-beta-lactamase inhibitory properties |
| 07/01/1998 | EP0850228A1 Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| 07/01/1998 | EP0850224A1 Radiation-activated cytotoxin therapy |
| 07/01/1998 | EP0850222A1 Piperazine derivatives and process for the preparation thereof |
| 07/01/1998 | EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/01/1998 | EP0850220A1 Cyclopropylindoles and their seco precursors, and their use as prodrugs |
| 07/01/1998 | EP0850215A1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 07/01/1998 | EP0850204A1 Photocatalytic coating substrate |
| 07/01/1998 | EP0850070A2 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 07/01/1998 | EP0850068A1 Lipid extract having anti-inflammatory activity |
| 07/01/1998 | EP0850067A1 Method for treating cancers using 6- 3- 1-adamantyl]-4-hydroxyphenyl] |
| 07/01/1998 | EP0850066A1 Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene |
| 07/01/1998 | EP0850065A1 Transdermal therapeutical system for silatran compounds |
| 07/01/1998 | EP0850064A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 07/01/1998 | EP0850063A1 Methods and compositions for treating fungal infections in mammals |
| 07/01/1998 | EP0850062A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 07/01/1998 | EP0850061A1 Immunosuppressant |
| 07/01/1998 | EP0850060A1 Zwitterionic forms of trovafloxacin |
| 07/01/1998 | EP0850059A1 Pharmaceutical formulations containing darifenacin |
| 07/01/1998 | EP0850058A1 Facilitation of ampa receptor-mediated synaptic transmission in brain as a treatment for schizophrenia |
| 07/01/1998 | EP0850057A1 Pharmaceutical compounds |
| 07/01/1998 | EP0850056A1 Topical anti-skin-cancer preparations |
| 07/01/1998 | EP0850055A2 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/01/1998 | EP0850054A1 Formulations of haloalkylamines and local anaesthetics and methods for the treatment of reflex sympathetic dystrophy (rsd) |
| 07/01/1998 | EP0850053A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 07/01/1998 | EP0850050A1 Oral fast-dissolving compositions for dopamine agonists |
| 07/01/1998 | EP0850048A2 Pharmaceutical granules |
| 07/01/1998 | EP0850047A1 Therapeutic lipidic vesicles: methods of use and compositions |
| 07/01/1998 | EP0822758A4 Supplement for baby infant formula and a method of delivering that supplement |
| 07/01/1998 | EP0814800A4 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 07/01/1998 | EP0809505A4 Method of treating chronic progressive vascular diseases |
| 07/01/1998 | EP0691972B1 FURO 3,2-b]PYRIDINES AND THIENO 3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 07/01/1998 | EP0639183B1 Nitrogen oxides of aza- and diaza-anthracenedione derivatives, their preparation and their use as antitumor agents |
| 07/01/1998 | EP0594581B1 Production of glycosides, especially of steroidal glycosides |
| 07/01/1998 | EP0527906B1 Inhibition of influenza virus replication by oligonucleotides |
| 07/01/1998 | EP0527845B1 Use of nickel and bromide ions for treating psoriasis |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186502A Compositions and methods for inhibiting thrombogenesis |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186499A Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186494A Antibacterial cephalosporins |
| 07/01/1998 | CN1186493A (R)-(2)-1-azabicyclo£2,2,1| heptan-3-one, O-£3-(3-methoxyphenyl)-2-propynyl| oxime maleate as a pharmaceutical agent |
| 07/01/1998 | CN1186492A Imidazo £1, 2-alpha| pyridine derivatives |
| 07/01/1998 | CN1186489A N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
| 07/01/1998 | CN1186487A Acetamide derivatives, process for producing the same, and medicinal composition containing the same |
| 07/01/1998 | CN1186485A Pyrole derivatives and medicinal composition |
| 07/01/1998 | CN1186473A Metered dose inhaler for beclomethasone dipropionate |
| 07/01/1998 | CN1186441A 脑水肿抑制剂 Brain edema inhibitors |
| 07/01/1998 | CN1186440A Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| 07/01/1998 | CN1186439A Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 07/01/1998 | CN1186436A Chemotherpeutic compositions |
| 07/01/1998 | CN1186435A Use of vitamin D4 derivatives for treating cancer |
| 07/01/1998 | CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride |
| 07/01/1998 | CN1186433A Use of benzimidazoles for manufacturing medicament for treatment of leukemia |
| 07/01/1998 | CN1186432A Use of pyrrolidine derivatives for treating alcoholism |
| 07/01/1998 | CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules |
| 07/01/1998 | CN1186430A Metered dose inhaler for albuterol |
| 07/01/1998 | CN1186427A Osmotic device with delayed activation of drug delivery and complete drug release |
| 07/01/1998 | CN1186366A Electric charging system for electric vehicle |
| 07/01/1998 | CN1186074A New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them |
| 07/01/1998 | CN1185952A Medicine for angiocardiopathy |
| 07/01/1998 | CN1185951A Skin nursing cream for curing comedo |
| 07/01/1998 | CN1185950A Oral composition containing dehydroepiandrosterone and its sodium sulfate |
| 07/01/1998 | CN1185949A Animal somatotropin |
| 07/01/1998 | CN1185948A Inhibitor for generation of 3-deoxyglucurone |
| 07/01/1998 | CN1185947A Composition for treatng condyloma acuminata |
| 07/01/1998 | CN1185946A Liquid for bathing pudendum |
| 07/01/1998 | CN1038937C Preparation of ergoline-8-carboxamides |
| 07/01/1998 | CN1038936C Preparation of methanamide derivatives |
| 07/01/1998 | CN1038935C Substituted biphenylpyridones and preparation of their salts |
| 07/01/1998 | CN1038932C Stereoselective preparation of substitued piperidines |
| 07/01/1998 | CN1038931C Preparation of medicinal compositions useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
| 07/01/1998 | CN1038929C Chelants processing ortho ligating functionality and complexes thereof |
| 07/01/1998 | CN1038928C Method for producing mono-fluoreinated derivatives of N-propargyl-1-aminoindan |
| 07/01/1998 | CN1038904C Preparation of megestrol acetate |
| 07/01/1998 | CN1038903C Agent for increasing somatostatin or for inhibiting decrcase of somatostatin |
| 06/30/1998 | US5773654 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds |
| 06/30/1998 | US5773647 Using a aromatic compound containing amide and carboxy groups |
| 06/30/1998 | US5773646 Integrin inhibitors |
| 06/30/1998 | US5773644 Cyclopropyl alkanoic acid derivatives |
| 06/30/1998 | US5773620 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present |
| 06/30/1998 | US5773612 Indol-2-one derivatives |
| 06/30/1998 | US5773610 Optically active 3-(1-(alkylamino))alkyl pyrrolidines |
| 06/30/1998 | US5773609 In vivo target tissue selectivity |
| 06/30/1998 | US5773601 Prevention of gene expression |
| 06/30/1998 | US5773600 DNA encoding pertussis toxin muteins |
| 06/30/1998 | US5773598 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 06/30/1998 | US5773580 Human protein kinase c inhibitor homolog |
| 06/30/1998 | US5773571 Peptide nucleic acids |
| 06/30/1998 | US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/30/1998 | US5773530 Pyrazolopyridine adenosine antagonists |
| 06/30/1998 | US5773479 Atherosclerosis, tamoxifen |